Sweden · Delayed Price · Currency is SEK Vimab Group AB Statistics
Total Valuation
Vimab Group AB has a market cap or net worth of SEK 127.47 million. The enterprise value is 225.73 million.
| Market Cap | 127.47M |
| Enterprise Value | 225.73M |
Important Dates
The next estimated earnings date is Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vimab Group AB has 47.56 million shares outstanding. The number of shares has increased by 27.64% in one year.
| Current Share Class | 47.56M |
| Shares Outstanding | 47.56M |
| Shares Change (YoY) | +27.64% |
| Shares Change (QoQ) | +63.34% |
| Owned by Insiders (%) | 15.96% |
| Owned by Institutions (%) | n/a |
| Float | 27.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| PB Ratio | 8.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 8.02.
| Current Ratio | 0.71 |
| Quick Ratio | 0.44 |
| Debt / Equity | 8.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.64 |
Financial Efficiency
Return on equity (ROE) is -837.71% and return on invested capital (ROIC) is -36.66%.
| Return on Equity (ROE) | -837.71% |
| Return on Assets (ROA) | -19.96% |
| Return on Invested Capital (ROIC) | -36.66% |
| Return on Capital Employed (ROCE) | -379.39% |
| Weighted Average Cost of Capital (WACC) | 5.32% |
| Revenue Per Employee | 1.89M |
| Profits Per Employee | -526,449 |
| Employee Count | 176 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 4.66 |
Taxes
| Income Tax | -503,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is -1.45, so Vimab Group AB's price volatility has been lower than the market average.
| Beta (5Y) | -1.45 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 3.99 |
| Relative Strength Index (RSI) | 42.86 |
| Average Volume (20 Days) | 2,427 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vimab Group AB had revenue of SEK 332.18 million and -92.66 million in losses. Loss per share was -3.03.
| Revenue | 332.18M |
| Gross Profit | 55.63M |
| Operating Income | -81.01M |
| Pretax Income | -93.16M |
| Net Income | -92.66M |
| EBITDA | -40.07M |
| EBIT | -81.01M |
| Loss Per Share | -3.03 |
Balance Sheet
The company has 15.81 million in cash and 114.08 million in debt, with a net cash position of -98.27 million or -2.07 per share.
| Cash & Cash Equivalents | 15.81M |
| Total Debt | 114.08M |
| Net Cash | -98.27M |
| Net Cash Per Share | -2.07 |
| Equity (Book Value) | 14.23M |
| Book Value Per Share | 0.30 |
| Working Capital | -67.65M |
Cash Flow
| Operating Cash Flow | -56.20M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 40.94M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 16.75%, with operating and profit margins of -24.39% and -27.89%.
| Gross Margin | 16.75% |
| Operating Margin | -24.39% |
| Pretax Margin | -28.04% |
| Profit Margin | -27.89% |
| EBITDA Margin | -12.06% |
| EBIT Margin | -24.39% |
| FCF Margin | n/a |
Dividends & Yields
Vimab Group AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.64% |
| Shareholder Yield | -27.64% |
| Earnings Yield | -72.69% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vimab Group AB has an Altman Z-Score of -1.56 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.56 |
| Piotroski F-Score | 4 |